Inhibition of influenza virus infection with chitosan-sialyloligosaccharides ionic complex.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Carbohydrate Polymers

• Publication date

  2014-07-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.carbpol.2014.02.048PMID 24702928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of receptor binding specificity in interspecies transmission of influenza viruses.

  2012cited by this paper
• Carbohydrate-functionalized chitosan fiber for influenza virus capture.

  2011cited by this paper
• Bovine milk as a source of functional oligosaccharides for improving human health.

  2011cited by this paper
• Chitins and Chitosans as Immunoadjuvants and Non-Allergenic Drug Carriers

  2010cited by this paper
• Chitosan-based formulations for delivery of DNA and siRNA.

  2010cited by this paper
• One-step synthesis of efficient binding-inhibitor for influenza virus through multiple addition of sialyloligosaccharides on chitosan

  2010cited by this paper
• Chitosan conjugated DNA nanoparticles in gene therapy

  2010cited by this paper
• Permeate from cheese whey ultrafiltration is a source of milk oligosaccharides.

  2009cited by this paper
• Oseltamivir-Resistant Influenza A Viruses Circulating in Japan

  2009cited by this paper
• Syntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl alpha(2-->3) lactose moieties as inhibitors for human influenza viruses.

  2009cited by this paper
• Synthetic sialic-acid-containing polyvalent antiviral inhibitors

  2009cited by this paper
• Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.

  2008cited by this paper
• Bovine milk glycome.

  2008cited by this paper
• Design of a sialylglycopolymer with a chitosan backbone having efficient inhibitory activity against influenza virus infection.

  2008cited by this paper
• Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a gamma-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses.

  2007cited by this paper
• Chemoenzymatic synthesis and application of a sialoglycopolymer with a chitosan backbone as a potent inhibitor of human influenza virus hemagglutination.

  2006cited by this paper
• Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern.

  2005cited by this paper
• Chitosan chemistry and pharmaceutical perspectives.

  2004cited by this paper
• Cell surface biology mediated by low affinity multivalent protein-glycan interactions.

  2004cited by this paper
• Concentrations of sialyloligosaccharides in bovine colostrum and milk during the prepartum and early lactation.

  2003cited by this paper
• Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(L-glutamic acid) backbone for inhibition of infection by influenza viruses.

  2003cited by this paper
• The annual production cycle for influenza vaccine.

  2003cited by this paper
• Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers.

  1999cited by this paper
• Simple synthesis of sialyllactose-carrying polystyrene and its binding with influenza virus

  1998cited by this paper
• Polyacrylamides Bearing Pendant α-Sialoside Groups Strongly Inhibit Agglutination of Erythrocytes by Influenza Virus: The Strong Inhibition Reflects Enhanced Binding through Cooperative Polyvalent Interactions

  1996cited by this paper
• Carbohydrate-Protein Interactions: Basis of Glycobiology

  1995cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Structure of the complex oligosaccharides of fetuin.

  1979cited by this paper

• Anti-COVID-19 Credentials of Chitosan Composites and Derivatives: Future Scope?

  2023cites this paper
• Development and Characterization of Antimicrobial Textiles from Chitosan-Based Compounds: Possible Biomaterials Against SARS-CoV-2 Viruses

  2022cites this paper
• Passive antifouling and active self-disinfecting antiviral surfaces

  2022cites this paper
• H5N1 Avian Flu Infection in Hubbard Broiler Chicken Can Be Prevented or Cured by Methylated Soy Protein During 42 Days Rearing

  2021cites this paper
• Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2?

  2021cites this paper
• Towards antiviral polymer composites to combat COVID‐19 transmission

  2021cites this paper
• Review of electrospun hydrogel nanofiber system: Synthesis, Properties and Applications

  2021cites this paper
• Carbohydrate-Based Macromolecular Biomaterials.

  2021cites this paper
• Antiviral effects of human milk oligosaccharides: A review

  2020cites this paper
• Smart polymeric eye gear: A possible preventive measure against ocular transmission of COVID-19

  2020cites this paper
• Chitosan Derivatives and Grafted Adjuncts with Unique Properties

  2019cites this paper
• One-pot reactive electrospinning of chitosan/PVA hydrogel nanofibers reinforced by halloysite nanotubes with enhanced fibroblast cell attachment for skin tissue regeneration.

  2019cites this paper
• Native and modified chitosan-based hydrogels as green heterogeneous organocatalysts for imine-mediated Knoevenagel condensation

  2016cites this paper